Primary treatment of epithelial ovarian malignancies

This publication has 21 references indexed in Scilit:

• Long-term survival in ovarian cancer
  European Journal of Cancer and Clinical Oncology, 1991
• Improved prognosis of ovarian cancer in The Netherlands during the period 1975–1985: A registry-based study
  Gynecologic Oncology, 1991
• Hexamethylmelamine for the treatment of ovarian cancer—The Mount Sinai experience
  Cancer Treatment Reviews, 1991
• Hexamethylmelamine (altretamine) activity as a single agent in previously untreated advanced ovarian cancer
  Cancer Treatment Reviews, 1991
• Randomized comparison of hexamethylmelamine, adriamycin, cyclophosphamide (hac) vs. cisplatin, adriamycin, cyclophosphamide (pac) in advanced ovarian cancer: long-term results
  Cancer Treatment Reviews, 1991
• A comparison of hexamethylmelamine (altretamine), cyclophosphamide, doxorubicin, and cisplatin (H-CAP) vs. cyclophosphamide, doxorubicin, and cisplatin (CAP) in advanced ovarian cancer
  Cancer Treatment Reviews, 1991
• Adjuvant Therapy in Stage I and Stage II Epithelial Ovarian Cancer
  New England Journal of Medicine, 1990
• Cyclophosphamide-Cisplatin Versus Cyclophosphamide-Carboplatin in Stage III-IV Ovarian Carcinoma: A Comparison of Equally Myelosuppressive Regimens
  JNCI Journal of the National Cancer Institute, 1989
• Carboplatin Substitution for Cisplatin in the Treatment of Ovarian Carcinoma-- A Word of Caution
  JNCI Journal of the National Cancer Institute, 1989
• RANDOMISED TRIAL COMPARING TWO COMBINATION CHEMOTHERAPY REGIMENS (HEXA-CAF VS CHAP-5) IN ADVANCED OVARIAN CARCINOMA
  The Lancet, 1984